Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Compass Pathways Plc ADR (CMPS)
Compass Pathways Plc ADR (CMPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 375,096
  • Shares Outstanding, K 61,897
  • Annual Sales, $ 0 K
  • Annual Income, $ -91,510 K
  • 60-Month Beta 2.56
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.48
Trade CMPS with:

Options Overview Details

View History
  • Implied Volatility 77.16% ( -10.92%)
  • Historical Volatility 73.00%
  • IV Percentile 68%
  • IV Rank 56.84%
  • IV High 97.13% on 10/19/23
  • IV Low 50.86% on 06/29/23
  • Put/Call Vol Ratio 999.99
  • Today's Volume 12
  • Volume Avg (30-Day) 200
  • Put/Call OI Ratio 0.21
  • Today's Open Interest 12,331
  • Open Int (30-Day) 14,054

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate -0.37
  • Number of Estimates 3
  • High Estimate -0.24
  • Low Estimate -0.62
  • Prior Year -0.73
  • Growth Rate Est. (year over year) +49.32%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.01 +17.37%
on 11/13/23
6.58 -10.64%
on 11/03/23
+0.60 (+11.26%)
since 10/27/23
3-Month
5.01 +17.37%
on 11/13/23
10.12 -41.89%
on 09/14/23
-3.23 (-35.46%)
since 08/28/23
52-Week
5.01 +17.37%
on 11/13/23
11.48 -48.78%
on 12/05/22
-3.56 (-37.71%)
since 11/28/22

Most Recent Stories

More News
Compass Pathways Plc (CMPS) Q3 2023 Earnings Call Transcript

CMPS earnings call for the period ending September 30, 2023.

CMPS : 5.89 (-2.81%)
The Breakthrough Therapy Aiming To Solve The World’s Mental Health Crisis

EQNX::TICKER_START (NYSE:JNJ),(NYSE:ABBV),(NASDAQ:ATAI),(NASDAQ:CMPS),(NASDAQ:MNMD) EQNX::TICKER_END

ABBV : 138.24 (-0.61%)
ATAI : 1.1300 (+4.63%)
CMPS : 5.89 (-2.81%)
MNMD : 3.01 (-0.66%)
JNJ : 151.40 (+0.08%)
3 Cathie Wood Stocks With Parabolic Growth Potential, According to Wall Street

These cutting-edge biotech stocks could deliver life-changing gains for early shareholders.

PFE : 29.67 (-1.56%)
BEAM : 29.28 (+0.41%)
CMPS : 5.89 (-2.81%)
MASS : 7.22 (+5.40%)
Compass Pathways Plc (CMPS) Q2 2023 Earnings Call Transcript

CMPS earnings call for the period ending June 30, 2023.

CMPS : 5.89 (-2.81%)
This Unexpected Development Is Yet Another Green Flag for Compass Pathways Stock

For biotechs developing psychedelic therapies, good news comes in many forms.

CMPS : 5.89 (-2.81%)
Global Psychedelic Therapeutics Market Size Expected To Reach $13.29 Billion By The Year 2031

EQNX::TICKER_START (NYSE:CYBN),NEO:CYBN),(NASDAQ:CMPS),(NASDAQ:MNMD),(NASDAQ:SEEL),(OTCQX:NUMIF) EQNX::TICKER_END

CYBN.NE : 0.6800 (+4.62%)
MMED.NE : 4.0500 (-1.46%)
CYBN : 0.4991 (+2.99%)
CMPS : 5.89 (-2.81%)
SEEL : 2.3300 (-26.94%)
MNMD : 3.01 (-0.66%)
NUMIF : 0.0778 (+0.13%)
NUMI.TO : 0.1050 (+5.00%)
Global Psychedelic Therapeutics Market Size Expected To Reach $13.29 Billion By The Year 2031

/PRNewswire/ -- Psychedelic and hallucinogenic medicines market have been growing consistently over the past several years and are expected to continue to rise...

NUMI.TO : 0.1050 (+5.00%)
CYBN : 0.4991 (+2.99%)
CMPS : 5.89 (-2.81%)
MNMD : 3.01 (-0.66%)
SEEL : 2.3300 (-26.94%)
NUMIF : 0.0778 (+0.13%)
Can Compass Pathways' Stock Gain 458% Like Wall Street Is Expecting?

Wall Street might have the timing wrong, but their hopes aren't misplaced.

CMPS : 5.89 (-2.81%)
Numinus to research COMP360 psilocybin therapy in treatment-resistant depression as part of large phase 3 study

/PRNewswire/ - Numinus Wellness Inc. (TSX: NUMI) is pleased to announce that Cedar Clinical Research (CCR) has begun studying COMP360 psilocybin therapy, an...

CMPS : 5.89 (-2.81%)
Compass Pathways Plc (CMPS) Q1 2023 Earnings Call Transcript

CMPS earnings call for the period ending March 31, 2023.

CMPS : 5.89 (-2.81%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

COMPASS Pathways plc is a mental health care company. It operates principally in New York, USA. COMPASS Pathways plc is headquartered in London, UK.

See More

Key Turning Points

3rd Resistance Point 7.25
2nd Resistance Point 6.90
1st Resistance Point 6.48
Last Price 5.89
1st Support Level 5.72
2nd Support Level 5.37
3rd Support Level 4.95

See More

52-Week High 11.48
Fibonacci 61.8% 9.01
Fibonacci 50% 8.24
Fibonacci 38.2% 7.48
Last Price 5.89
52-Week Low 5.01

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar